LINC02209: A Potential Drug Target Or Biomarker (G286135)

Target Name: LINC02209

NCBI ID: G286135

Other Name(s): FAM183CP | Long intergenic non-protein coding RNA 2209 | long intergenic non-protein coding RNA 2209

LINC02209: A Potential Drug Target Or Biomarker

LINC02209 (FAM183CP) is a protein that is expressed in various tissues and organs, including the brain, heart, and kidneys. It is a member of the FAM183 family of proteins, which are known for their role in intracellular signaling. LINC02209 has been shown to play a role in a variety of physiological processes, including cell survival, metabolism, and inflammation. As a result, it has potential as a drug target or biomarker.

The FAM183 family of proteins is characterized by the presence of a conserved domain that includes a leucine-rich repeat (LRR) and a carboxylic acid residue (CAR). This domain is present in multiple proteins, including LINC02209, and is thought to play a role in protein-protein interactions and intracellular signaling.

One of the unique features of LINC02209 is its ability to form a protein-protein interaction complex with other proteins. This interaction is thought to play a role in the regulation of various cellular processes, including cell survival, metabolism, and inflammation. For example, LINC02209 has been shown to interact with the protein p53, which is a well-known regulator of DNA damage repair and cell survival.

In addition to its role in intracellular signaling, LINC02209 has also been shown to play a role in the regulation of cellular processes outside of the cell. For example, it has been shown to play a role in the regulation of inflammation, as well as cell. migration and the assembly of tissues.

Given its potential role in a variety of cellular processes, LINC02209 has attracted the interest of researchers as a potential drug target or biomarker. Studies have shown that LINC02209 can be targeted by small molecules, including inhibitors of protein-protein interactions and inhibitors of intracellular signaling pathways. In addition, LINC02209 has been shown to be expressed in a variety of tissues and organs, including the brain, heart, and kidneys, which makes it a potential biomarker for a variety of diseases.

In conclusion, LINC02209 is a protein that has potential as a drug target or biomarker due to its role in intracellular signaling and its ability to form protein-protein interaction complexes. Further research is needed to fully understand the mechanisms of LINC02209's role in cellular processes and its potential as a drug or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2209

More Common Targets